(Q52082926)

21 April 2018

title

Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. (English)

1 reference

21 April 2018

1 reference

1 reference

myocardial infarction

1 reference

4

1 reference

21 April 2018

Paul W. Armstrong

9

1 reference

21 April 2018

Eric J. Topol

11

1 reference

21 April 2018

Robert Califf

2

object named as

Califf RM

1 reference

21 April 2018

5

Ohman EM

1 reference

21 April 2018

Hasdai D

1

1 reference

21 April 2018

Thompson TD

3

1 reference

21 April 2018

Pfisterer M

6

1 reference

21 April 2018

Bates ER

7

1 reference

21 April 2018

Vahanian A

8

1 reference

21 April 2018

Criger DA

10

1 reference

21 April 2018

Holmes DR Jr

12

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

21 April 2018

Journal of the American College of Cardiology

published in

1 reference

21 April 2018

volume

35

1 reference

21 April 2018

issue

1

1 reference

21 April 2018

page(s)

136-143

1 reference

21 April 2018

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

1 reference

7 January 2021

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Shock after acute myocardial infarction. A clinical and hemodynamic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Prognosis in cardiogenic shock after acute myocardial infarction in the intervencional era

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Usefulness of coronary stenting for cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) tria

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Determinants of the Use of Coronary Angiography and Revascularization after Thrombolysis for Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Clinical predictors easily obtained at presentation predict resource utilization in unstable angina.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Inv

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900508-2

7 January 2021

10.1016/S0735-1097(99)00508-2

Identifiers

DOI

1 reference

21 April 2018

release_hhkbdmt3tjdunpcyohzt3rwyyu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hhkbdmt3tjdunpcyohzt3rwyyu

24 November 2022

mapped directly with Wikidata item

1 reference

21 April 2018